Kavita Iyer

Scientific Content Creator and Writer, CAS

Bio

Kavita Iyer graduated with a Bachelor of Pharmacy from the University of Mumbai in 2011. Subsequently she earned her PhD in Medicinal Chemistry from Virginia Commonwealth University, USA. She further pursued a post-doctoral fellowship in the Department of Physiology and Biophysics at VCU where she was trained as a structural biologist and subsequently worked as a Research Scientist. Prior to joining CAS, she worked briefly at ACSII.

Biotechnology

O xenotransplante poderia resolver a escassez de órgãos para transplante?

Com o advento da tecnologia de edição genética, os pesquisadores estão cada vez mais aptos a lidar com questões de imunocompatibilidade, aproximando-se de tornar órgãos e tecidos disponíveis para transplante de doadores animais para receptores humanos.
|Artigo
Drug Discovery

PPI inhibitors show promise in cancer trials

Small molecule PPI inhibitors are on the brink of improving cancer treatments
|Artigo
Emerging Science

Co-occurring concepts reveal new research directions in immuno-oncology

Concept co-occurrence analysis shows the newest ideas in scientific discovery and drives innovation in immuno-oncology.
|Artigo
Drug Discovery

PROTACs revolutionize small molecule drugs

PROTACs are driving small molecule drug development to treat cancer, neurodegenerative diseases and more
|Artigo
Biotechnology

Webinar: Big data insights in the quest to cure cancer

Experts discuss emerging trends in immuno-oncology, data challenges, and opportunities ahead for cancer researchers.
|ウェビナー
Drug Discovery

Emerging trends in immunotherapy and cancer

Immuno-oncology has the potential to treat cancer without sacrificing the patient's wellbeing.
|Artigo